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Research has indicated that consuming medium-chain triglycerides (MCT) may be more 30 
satiating than consuming long-chain triglycerides (LCT) potentially causing a reduction in 31 
energy intake.  However not all studies have demonstrated this acute reduction in energy intake 32 
and it has yet to be systematically reviewed. Our main objective was to examine how ingestion 33 
of MCT influences energy intake, subjective appetite ratings and appetite-related hormones 34 
compared to LCT. Web of Science, MEDLINE, CINHAL and Embase were searched for 35 
publications comparing the effect of MCT on appetite (commonly hunger, fullness, desire to 36 
eat, and prospective food consumption), appetite-related hormones (pancreatic polypeptide 37 
(PP), gastric inhibitory polypeptide (GIP), peptide YY (PYY), glucagon-like peptide-1 (GLP-38 
1), neurotensin, leptin, total ghrelin and active ghrelin) and energy intake to LCT. A random-39 
effects meta-analysis was conducted on studies which examined energy intake.  40 
Seventeen studies (291 participants) were included in the systematic review, of which 11 were 41 
included in the energy intake meta-analysis. Synthesis of combined data showed evidence of a 42 
statistically significant moderate decrease in ad libitum energy intake after both acute and 43 
chronic ingestion of MCT compared to LCT when assessed under laboratory conditions (mean 44 
effect size: -0.444, 95% CI -0.808, -0.080, p < 0.017), despite little evidence of any effect of 45 
MCT on subjective appetite ratings or circulating hormones.  46 
The current evidence supports the notion that MCT decreases subsequent energy intake, but 47 
does not appear to affect appetite. Further research is warranted to elucidate the mechanisms 48 
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Introduction 53 
Overweight and obesity are defined as the accumulation of excess body fat which may lead to 54 
impaired health (World Health Organisation 2018). Despite the well-reported risks of increased 55 
body fat, including type 2 diabetes, coronary heart disease, some cancers, and stroke (National 56 
Health Service 2016), overweight and obesity are still increasingly prevalent. In 2016, more 57 
than 1.9 billion adults were overweight globally and 650 million of these were obese; figures 58 
which have nearly tripled since 1975 (World Health Organisation 2018). These conditions are 59 
caused by a chronic energy surplus from either excessive energy intake or inadequate energy 60 
expenditure (Hill, Wyatt, and Peters 2012). It is known that adherence to dietary interventions 61 
aiming to reduce bodyweight is low due to feelings of hunger (Franklin et al. 1948), meaning 62 
that the target weight loss is not always achieved.  63 
As a result of this, foods with enhanced satiety have gained much attention, both commercially 64 
and in research (Hetherington et al. 2013; Chambers, McCrickerd, and Yeomans 2015). 65 
Medium-chain triglycerides (MCT) are triglycerides with shorter chain lengths (6-12 carbon 66 
atoms long) than ‘traditional’ long-chain triglycerides (LCT; 12+ carbon atoms long). Due to 67 
the shorter chain length of MCT, its consumption results in attenuated release of 68 
cholecystokinin (CCK) compared to LCT (Feltrin et al. 2007, 2006; Feinle et al. 2001; 69 
Matzinger et al. 2000; French et al. 2000). CCK is involved in lipid-related satiety (McLaughlin 70 
et al. 1999), and thus LCT promote satiety via this mechanism. However, MCT are absorbed 71 
much quicker than LCT (Marten, Pfeuffer, and Schrezenmeir 2006) which leads to large 72 
amounts of β-oxidation (Bach and Babayan 1982) and the production of β-hyroxybutyrate 73 
(Page et al. 2009); a process which is thought to be anorexigenic (Laeger, Metges, and Kuhla 74 
2010; Scharrer 1999). Studies have shown decreased appetite and subsequent energy intake 75 
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after a preload (Rolls et al. 1988), breakfast (Coleman, Quinn, and Clegg 2016; Kinsella, 76 
Maher, and Clegg 2017; Van Wymelbeke et al. 1998) or lunch (Van Wymelbeke, Louis-77 
Sylvestre, and Fantino 2001) containing MCT. This is not a universal finding however, as some 78 
studies have reported no difference in energy intake after meals containing MCT or a control 79 
oil (St-Onge et al. 2014; Poppitt et al. 2010), and have even shown increased feelings of hunger 80 
after MCT-based meals (Valente et al. 2018). 81 
Clearly, the findings surrounding MCT and satiety are mixed. It is therefore important to 82 
systematically determine whether MCT ingestion results in greater satiety and decreased 83 
energy intake. Thus, this review aims to assess if there is sufficient evidence to support the 84 
hypothesis that MCT can increase satiety in comparison with LCT. Specifically, the objectives 85 
are to examine if the consumption of MCT decreases energy intake in subsequent eating 86 
episodes, if MCT ingestion favourably alters subjective sensations of appetite (i.e. increased 87 
fullness and decreased hunger/desire to eat), and to compile the data on the effects of MCT on 88 
circulating hormones involved in appetite regulation. 89 
 90 
Methods  91 
This review is reported according to the PRISMA guidelines (Moher et al. 2009), and is 92 
registered in the PROSPERO database (registration number: CRD42018092550). 93 
Search Strategy 94 
The research question of this systematic review was formulated using PICOS (Population, 95 
Intervention, Comparison, Outcome, Setting). The population was defined as adults of healthy 96 
status excluding overweight or obesity. The intervention was considered to be any investigation 97 
examining medium-chain triglycerides or medium-chain fatty acids on appetite and satiety 98 
measures. Outcomes incorporated any measure of appetite (i.e. visual analogue scales), 99 
physiological markers of appetite regulation (e.g. PYY, ghrelin) and energy intake measures 100 
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(ad libitum meals, diet diaries). There was no restriction to the settings in which studies were 101 
conducted. 102 
The databases Web of Science, MEDLINE, CINHAL and Embase were searched for studies 103 
in the English language between 1970 and 2018 comprising of all human participants using the 104 
strategy (“medium chain triglycerides” AND “satiety” AND “human”). The last search was 105 
run on 14 May 2018. Previous systematic reviews were screened to identify relevant subject 106 
headings and key words to include within each subject category. Reference lists from the 107 
resulting articles were also screened to identify any additional articles. Table 1 shows a full 108 
list of the specific key words. 109 
Exclusion criteria 110 
Studies were excluded if they did not examine MCT or medium chain fatty acids (or a product 111 
containing either) and subjective measurement of appetite sensations or energy or food intake. 112 
Studies were also excluded if they were conducted in animals, or if they contained individuals 113 
outside the age range of 18-70 years, or if they did not include an LCT arm that was matched 114 
in calories and composition to an MCT arm.  115 
Data Screening 116 
Records were screened for duplicates, which were removed. Potential studies were identified 117 
by examining all titles and removing those which did not contain reference to MCT and appetite 118 
or energy intake by one reviewer. The abstracts of the remaining titles were read, and full text 119 
copies were obtained if they still met the initial criteria. Information on the remaining studies 120 
after abstract screening was tabulated by one researcher (TM), and both investigators (TM and 121 
MC) discussed the inclusion of the studies until a mutual consensus was met. The following 122 
information was extracted from the included into a spreadsheet: authors, date of publication, 123 
sample size, participant characteristics (age, sex, body mass index [BMI]), study setting, source 124 
and amount of MCT, appetite outcome measures and results. 125 
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Quality Checks 126 
Risk of bias was assessed within the individual studies using the Cochrane Collaboration’s 127 
Tool (Higgins et al. 2011). Selection bias, reporting bias, performance bias, detection bias, 128 
attrition bias and other sources of bias (such as funding etc.) were assessed. Eligible studies 129 
were included regardless of risk of bias. Table 2 details risk of all sources of bias for each 130 
study.   131 
Meta-analysis procedures 132 
Due to inconsistent reporting of visual analogue scale data (i.e. presented in a variety of ways, 133 
graphical format, as raw data or calculated AUC), and the small number of studies examining 134 
appetite hormones (four), only acute ad libitum energy intake data was included in the meta-135 
analysis (either at a single meal or over the course of a whole day). The remaining 11 studies 136 
were broken down into 20 subgroups, accounting for studies investigating multiple doses of 137 
MCT (Rolls et al. 1988, Stubbs and Harbron 1996) or coconut oil (Rizzo et al. 2016), and for 138 
studies with multiple investigations (St-Onge et al. 2014). Energy intake (kJ) was measured at 139 
both ad libitum meals and habitual daily intake. Where needed, reported values were converted 140 
to kJ before computation to standardise the units. Meta-analysis software (Comprehensive 141 
Meta-Analysis, Version 3, Biostat, Englewood, NJ, USA) was used to conduct a meta-analysis 142 
on extracted data. Data inputted included sample sizes, mean energy intake for LCT and MCT 143 
trials, their respective SDs, and a correlation coefficient to account for the fact that the included 144 
studies were crossover trials (r = 0.940, calculated from energy intake data from the studies 145 
included in the review). The software computed effect sizes for each study, as well as an overall 146 
effect size using a random-effects model (DerSimonian-Laird inverse variance approach). 147 
Effect size was calculated as the standardised difference in means, which we interpreted to be 148 
trivial at <0.2, small at 0.2-0.3, moderate at 0.4-0.8, and large at >0.8, as per Cohen (Cohen 149 
1992). Negative effect sizes indicate decreased consumption in MCT trials/conditions, whereas 150 
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positive effect sizes indicated LCT led to decreased energy intake. Publication bias was 151 
assessed utilising funnel plots and by quantifying Egger’s regression intercept. A significant 152 




The database search yielded 4,547 results, which was reduced to 3,517 after the removal of 157 
duplicates. After the screening of titles and abstracts, 3,302 were removed. Of the remaining 158 
216 texts, 17 satisfied the inclusion criteria (Figure 1.). 159 
Seven studies were conducted in the UK (Clegg, Golsorkhi, and Henry 2013; Clegg et al. 2012; 160 
Coleman, Quinn, and Clegg 2016; Kinsella, Maher, and Clegg 2017; Stubbs and Harbron 1996; 161 
Rizzo et al. 2016), two in Australia (Feltrin et al. 2004, 2008), two in France (Van Wymelbeke 162 
et al. 1998; Van Wymelbeke, Louis-Sylvestre, and Fantino 2001), two in the US (St-Onge et 163 
al. 2014; Rolls et al. 1988), and one each in Italy (Barbera et al. 2000), Sweden (Krotkiewski 164 
2001), Brazil (Valente et al. 2018), and New Zealand (Poppitt et al. 2010). Participants were 165 
28.57 ± 6.20 years of age with a BMI of 23.49 ± 3.42 kg/m2, and there was an average of 15 ± 166 
8 participants per study (means ± SD). Participants in one study were classified as ‘overweight’ 167 
according to BMI (M. St-Onge et al. 2014), and were classified as ‘obese’ in one other 168 
(Krotkiewski 2001); all others were in the ‘normal’ BMI category. There was a total of 291 169 
participants, of which 107 were male and 184 were female. There were 11 acute feeding studies 170 
( Rolls et al. 1988; Clegg, Golsorkhi, and Henry 2013; Coleman, Quinn, and Clegg 2016; 171 
Kinsella, Maher, and Clegg 2017; Rizzo et al. 2016; Miriam E. Clegg et al. 2012; M. St-Onge 172 
et al. 2014; Valente et al. 2018; Van Wymelbeke et al. 1998; Van Wymelbeke, Louis-Sylvestre, 173 
and Fantino 2001; Poppitt et al. 2010), three acute infusion studies (Barbera et al. 2000; Feltrin 174 
et al. 2008, 2004), and two chronic dietary intervention studies, of which one examined 175 
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participants three times across all arms of the intervention and quantified habitual daily energy 176 
intake (Stubbs and Harbron 1996) and the other was a comparison of independent matched 177 
groups (Krotkiewski 2001). One dietary intervention provided all foods consumed by 178 
participants in 14-day long manipulations, where the amount of energy from MCT was altered 179 
(Stubbs and Harbron 1996), and the other was a very low calorie diet, with either MCT or LCT 180 
was incorporated into the low-calorie formula incorporated into the diet (Krotkiewski 2001). 181 
Measures 182 
Fourteen out of fifteen studies used 100mm visual analogue scales to measure subjective 183 
sensations of appetite (St-Onge et al. 2014). Ten studies examined energy intake during at least 184 
one subsequent ad libitum eating episode after consumption of a meal/preload containing 185 
LCT/MCT (Rizzo et al. 2016; Coleman, Quinn, and Clegg 2016; Feltrin et al. 2004; Kinsella, 186 
Maher, and Clegg 2017; Poppitt et al. 2010; Feltrin et al. 2008; Rolls et al. 1988; St-Onge et 187 
al. 2014; Van Wymelbeke, Louis-Sylvestre, and Fantino 2001; Van Wymelbeke et al. 1998),  188 
and one examined daily habitual energy intake after MCT was covertly incorporated into the 189 
diet (Stubbs and Harbron 1996). In that study, participants were required to consume all meals 190 
in the laboratory, but were allowed to leave and were not required to ‘live’ in the laboratory; 191 
and thus ad libitum daily energy intake was quantified. Three of those also included diet diaries 192 
for subsequent energy intake (Coleman, Quinn, and Clegg 2016; Kinsella, Maher, and Clegg 193 
2017; Van Wymelbeke et al. 1998). Four studies examined appetite hormones, including 194 
pancreatic polypeptide (PP) (Barbera et al. 2000), CCK (Barbera et al. 2000; Feltrin et al. 2004, 195 
2008), gastric inhibitory polypeptide (GIP) (Barbera et al. 2000; Feltrin et al. 2004), peptide 196 
YY (PYY) (Feltrin et al. 2008; St-Onge et al. 2014), leptin (St-Onge et al. 2014), glucagon-197 
like peptide-1 (GLP-1) (Feltrin et al. 2004) and both active and total ghrelin (St-Onge et al. 198 
2014). 199 
Test lipids 200 
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The main results of included studies are shown in Table 3. Six studies directly compared MCT 201 
to LCT, which acted as a control (Barbera et al. 2000; Clegg, Golsorkhi, and Henry 2013; 202 
Feltrin et al. 2004; Rolls et al. 1988; St-Onge et al. 2014; Stubbs and Harbron 1996). Two 203 
studies compared MCT and LCT, and also included a low-fat/no-fat control (Feltrin et al. 2008; 204 
Krotkiewski 2001; Van Wymelbeke, Louis-Sylvestre, and Fantino 2001). Three studies had 205 
multiple fats, including several LCT conditions such as sunflower oil, olive oil and butter 206 
(Clegg et al. 2012); olive oil and lard (Van Wymelbeke et al. 1998); and two with another test 207 
oil, which was conjugated linoleic acid (Coleman, Quinn, and Clegg 2016) and short-chain 208 
triglycerides (Poppitt et al. 2010). Two studies used coconut oil as the source of MCT in the 209 
study (Rizzo et al. 2016; Valente et al. 2018), and another study used coconut oil as well as 210 
MCT (Kinsella, Maher, and Clegg 2017). For the LCT trials and controls, three studies used 211 
sunflower oil (Clegg, Golsorkhi, and Henry 2013; Clegg et al. 2012; Rizzo et al. 2016), two 212 
used rapeseed oil (Coleman, Quinn, and Clegg 2016; Kinsella, Maher, and Clegg 2017), two 213 
used corn oil (Rolls et al. 1988; St-Onge et al. 2014), one used beef tallow (Poppitt et al. 2010), 214 
one used extra virgin olive oil (Valente et al. 2018), one used margarine (Van Wymelbeke, 215 
Louis-Sylvestre, and Fantino 2001), one study used an unspecified vegetable oil (Stubbs and 216 
Harbron 1996), and three studies (which administered the lipids via infusion and not feeding) 217 
used emulsions of oleic and linoleic acid (Barbera et al. 2000), oleic acid (Feltrin et al. 2008), 218 
and lauric acid (Feltrin et al. 2004). One study did not specify the LCT used in their study 219 
(Krotkiewski 2001). In terms of saturation of LCT, six studies utilised LCT with a mixture of 220 
polyunsaturated and monounsaturated acids (Barbera et al. 2000; Rolls et al. 1988; Clegg, 221 
Golsorkhi, and Henry 2013; St-Onge et al. 2014; Rizzo et al. 2016; Valente et al. 2018), four 222 
used purely monounsaturated fatty acids (Kinsella, Maher, and Clegg 2017; Coleman, Quinn, 223 
and Clegg 2016; Stubbs and Harbron 1996; Feltrin et al. 2008), two used mixtures of 224 
monounsaturated and saturated fatty acids (Van Wymelbeke, Louis-Sylvestre, and Fantino 225 
10 
 
2001; Poppitt et al. 2010), and two studies used multiple sources of LCT; polyunsaturated and 226 
monounsaturated (sunflower oil), monounsaturated (olive oil) and saturated (butter) fatty acids 227 
(Clegg et al. 2012), and saturated (lard) or monounsaturated (olive oil) (Van Wymelbeke et al. 228 
1998). When accounting for studies that provided multiple doses, the dosage of MCT ranged 229 
from 10 g (Poppitt et al. 2010) to 42.4 g (Van Wymelbeke et al. 1998), with an average dose 230 
of 23.8 g. Three studies provided 10-15 g (Poppitt et al. 2010; Rolls et al. 2004; Rizzo et al. 231 
2016), four provided 20-25 g (Coleman, Quinn, and Clegg 2016; Kinsella, Maher, and Clegg 232 
2017; St-Onge and Jones 2002; Rolls et al. 2004), three provided 30-35 g (St-Onge et al. 2014; 233 
Van Wymelbeke, Louis-Sylvestre, and Fantino 2001; Rolls et al. 1988) and one provided 40-234 
45 g (Van Wymelbeke et al. 1998). 235 
Outcomes 236 
One out of 11 studies (Feltrin et al. 2004) reported decreased energy intake at an ad libitum 237 
meal after MCT compared to LCT, although this was only significant in seven studies 238 
(Coleman, Quinn, and Clegg 2016; Feltrin et al. 2008; Rolls et al. 1988; St-Onge et al. 2014; 239 
Stubbs and Harbron 1996; Van Wymelbeke, Louis-Sylvestre, and Fantino 2001; Van 240 
Wymelbeke et al. 1998). The one study that reported decreased intake after LCT compared to 241 
MCT reported a significantly lower energy intake after LCT compared to MCT (Feltrin et al. 242 
2004). The average energy intake at the ad libitum meal in that study after LCT and MCT trials, 243 
respectively, was 1,747 ± 633 kJ and 4,109 ± 589 kJ. Five studies out of 14 reported significant 244 
differences in appetite ratings, which were decreased hunger and increased satiety after MCT 245 
(Krotkiewski 2001), increased fullness after MCT (Kinsella, Maher, and Clegg 2017), 246 
increased satiety after LCT (Barbera et al. 2000), decreased hunger but also decreased desire 247 
to eat after infusion of MCT (Feltrin et al. 2004), and increased hunger and decreased fullness 248 
after MCT (coconut oil) (Valente et al. 2018). Three studies (Rolls et al. 1988; Feltrin et al. 249 
2004; Barbera et al. 2000) reported significant adverse effects, which manifested as gastric 250 
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aching after the MCT drinks ( Rolls et al. 1988), and increased nausea after infusions LCT 251 
compared to MCT (Barbera et al. 2000; Feltrin et al. 2004). 252 
Only four studies examined blood parameters in response to the oils which showed LCT led to 253 
increased postprandial concentrations GIP, neurotensin, PP (Barbera et al. 2000), CCK 254 
(Barbera et al. 2000; Feltrin et al. 2008, 2004), PYY (Feltrin et al. 2008) and GLP-1 (Feltrin et 255 
al. 2004). Conversely, one study showed that relative to MCT, LCT led to increased 256 
postprandial leptin and PYY, and no effect on GLP-1 or total ghrelin, but active ghrelin 257 
concentrations were reduced to a lesser extent after MCT (St-Onge et al. 2014). 258 
Meta-analysis 259 
Due to high levels of heterogeneity (I2 = 97.0%, Q = 333.9, T2= 0.355, df = 10), a random 260 
effects model was chosen (Ades, Lu, and Higgins 2005). Effect size for acute ad libitum energy 261 
intake ranged from -2.235 to 3.789. Statistics for each individual study are reported in 262 
Supplementary table 1. There was a statistically significant moderate decrease in ad libitum 263 
energy intake after MCT ingestion compared to LCT ingestion (mean effect size: -0.444, 95% 264 
confidence intervals -0.808 to -0.0.80, N = 11, p = 0.017; Figure 2). Sensitivity analysis showed 265 
that the removal of each study had only minor effects on overall effect size, and no effect on 266 
significance. In order to further examine and specify the effect of consuming MCT on satiety, 267 
a sensitivity analysis was conducted by removing infusion studies. This did not alter the 268 
direction of significance, but it did increase the level of significance (mean effect size: -0.681, 269 
95% confidence intervals -0.950 to -0.412, N = 8, p < 0.001). More sensitivity analyses were 270 
conducted in order to specify the effect of MCT without the influence of coconut oil. Similarly 271 
to the removal of infusion studies, removal of the comparison of LCT to coconut oil increased 272 
the size of the effect of MCT on energy intake (mean effect size: -0.529, 95% confidence 273 
intervals -0.598 to -0.460, N = 10, p < 0.001). The funnel plot (Figure 3.) along with Egger’s 274 
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regression intercept showed that there were no small study effects (intercept = -1.094, 95% 275 
confidence intervals: -11.481 to 9.293, p = 0.817).  276 
 277 
Discussion 278 
Main results 279 
Prior to this review, MCT had been identified as potentially having more satiating properties 280 
than LCT, but studies investigating this are sparse and have found equivocal findings. 281 
Understanding how MCT may affect appetite may have implications for weight management, 282 
as feelings of hunger are known to the linked to the low rates of adherence commonly seen in 283 
dietary strategies (Heymsfield et al. 2007; Franklin et al. 1948). Whereas it is well known that 284 
protein is the most satiating of the macronutrients and fat the least, a significant portion of 285 
energy in the western diet comes from fat, and therefore methods to increase the satiety 286 
response to fat has implications for weight management strategies. The purpose of this review 287 
was to examine the appetite responses and energy intake after meals containing either MCT or 288 
LCT. It was hypothesised that MCT would increase satiety compared to LCT. The analyses 289 
show that MCT suppress energy intake compared to LCT, and this appears to be independent 290 
of changes in subjective sensations of appetite and alterations in gut peptide hormones.  291 
Energy intake 292 
The present meta-analysis showed that nine out of 10 studies reported decreased energy intake 293 
at an acute ad libitum meal after ingestion or infusion of MCT, and the only study examining 294 
habitual energy intake when MCT was incorporated into the diet also led to decreased energy 295 
intake compared to LCT. Whereas the decreased energy intake after MCT consumption wasn’t 296 
significant in all individual studies, the meta-analysis demonstrated a moderate effect of MCT 297 
on energy intake compared to LCT. However, it must be noted that these findings are 298 
predominantly limited to the first meal after ingestion of MCT and cannot be extrapolated to 299 
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further meals. More research is needed to elucidate whether compensation occurs in later 300 
meals, or if an energy deficit is achieved. One study did incorporate MCT as part of the habitual 301 
diet in different MCT:LCT ratios and found that habitual daily intake was lower after the high 302 
MCT:LCT ratio period (Stubbs and Harbron 1996). Where this does corroborate the hypothesis 303 
that chronic consumption of MCT decreases overall intake; whether this is due to repeat 304 
exposure of MCT or a persistent effect is still not known. Furthermore, as only one study to 305 
date has investigated chronic MCT consumption and habitual energy intake, these results 306 
require validation. 307 
Appetite 308 
Despite reported alterations in energy intake, this appears to have occurred without any 309 
reporting of an effect on subjective appetite responses, indicating that MCT suppresses ad 310 
libitum energy intake without a concomitant change of feelings of hunger. As aforementioned, 311 
this requires further investigation as there is a lack of studies investigating energy intake 312 
beyond a single ad libitum meal or a single day. Extraction of subjective sensation data was 313 
challenging due to the inconsistent reporting of raw values (i.e. only represented in graphical 314 
format), and so these were not included in the meta-analysis. Inspection of the results (Table 315 
3) shows that the majority of studies do not report significant differences in any subjective 316 
sensation parameter, and when a difference is reported it is not consistent in all parameters in 317 
the study (Barbera et al. 2000; Clegg et al. 2012; Kinsella, Maher and Clegg 2017; Stubbs and 318 
Harbron 1996; Valente et al. 2017). The only study to show consistent changes in subjective 319 
sensations of appetite incorporated MCT into the diet as part of a very low-calorie diet for 4 320 
weeks (Krotkieski 2001). It is possible that acute feedings of MCT do not alter perceptions of 321 




Only four studies examined appetite-related hormones, and so drawing conclusions from these 324 
studies is mere speculation; however, secretion of CCK, GIP, PP or GLP-1 appears to be more 325 
potent after LCT than MCT. Additionally, another study showed that active ghrelin may be 326 
suppressed to a lesser extent than after LCT. MCT have been shown to increase stomach 327 
concentrations of acylated ghrelin, as MCT and MCFA are directly used for the acylation of 328 
ghrelin (Nishi et al. 2005), which may explain the suppression by LCT. Ghrelin is the only 329 
appetite hormone known to stimulate hunger (Wren et al. 2000), whereas CCK, GIP, PP and 330 
GLP-1 are involved in promoting satiety and satiation (Gibbs, Young, and Smith 1973; 331 
Kissileff et al. 1981; Batterham et al. 2002; Flint et al. 2001; Perry and Wang 2012). Taken 332 
together, this implies that MCT exert its anorectic affect through non-hormone mediated 333 
mechanisms, however the paucity of data makes this speculation. MCT have been shown to 334 
delay gastric emptying (Clegg et al. 2012), despite MCFA being absorbed at a much quicker 335 
rate than LCFA (Bach and Babayan 1982). MCT consumption also leads to the production of 336 
the ketone body of β-hyroxybutyrate, which may also be anorexigenic (Laeger, Metges, and 337 
Kuhla 2010). Future studies should include these measures in their protocols in order to shed 338 
further light on these mechanisms.  339 
The one study that found greater ad libitum energy intake after MCT compared to LCT (Feltrin 340 
et al. 2004) compared lauric acid (C12) to decanoic (C10) acid via intraduodenal infusion and 341 
observed significant differences in ad libitum energy intake. This was accompanied by greater 342 
stimulation of CCK and GLP-1 after infusion of C12. This suggests that the longer chain length 343 
is more efficacious at decreasing appetite. It has previously been reported incretin responses to 344 
infusions of glucose and lipids are not as pronounced as the response to oral ingestion of 345 
glucose (Elrick et al. 1964) or lipids (Lindgren et al. 2011). As such, this makes drawing 346 
conclusions from infusion studies difficult. It must also be noted that infusion of C12 induced 347 
nausea, which may also explain the decreased ad libitum energy intake. This increased nausea 348 
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was also found after the infusion of LCT but not MCT (Barbera et al. 2000), which also may 349 
explain increased satiation scores in that study. Only one other study which examined energy 350 
intake reported adverse effects, which were in the form of ‘gastric aching’ (Rolls et al. 1988), 351 
which also may partly explain the decreased ad libitum energy intake after MCT ingestion in 352 
that study. In the first study to examine MCT and satiety (Rolls et al. 1988), there was a 353 
significant interaction between fatty acid chain length and dosage for gastric aching, suggesting 354 
that increased dosage of MCT was linked to stronger adverse effects. However, higher doses 355 
have been examined with no adverse effects (Van Wymelbeke, Louis-Sylvestre, and Fantino 356 
2001; Van Wymelbeke et al. 1998), and the authors describe that, despite statistically 357 
significant differences, absolute differences were small (3.5 mm on a 100 mm scale). Only five 358 
of the studies included a rating of nausea (Barbera et al. 2000; Feltrin et al. 2008, 2004; Poppitt 359 
et al. 2010; Clegg, Golsorkhi, and Henry 2013), which may also confound the effect observed 360 
in our meta-analysis, as (although only two studies reported adverse effects) MCT have been 361 
shown to cause GI distress (Jeukendrup et al. 1998; Goedecke et al. 2005) and are generally 362 
unpalatable (Clegg 2010; Maher and Clegg 2018). 363 
Methodology 364 
The dosages of MCT provided in the studies included in this review had a large variation (10 365 
g (Poppitt et al. 2010) to 42.4 g (Van Wymelbeke et al. 1998) with an average dose of 23.8 g). 366 
There did not appear to be a relationship between dose and whether there was an effect on 367 
energy intake, as despite the study providing the lowest dose reported no effect (Poppitt et al. 368 
2010), another study found significant effects with all three doses administered in their study; 369 
the lowest providing 12.04 g of MCT (Rolls et al. 1988). Furthermore, the greatest decrease 370 
observed after MCT ingestion occurred after 30 g of MCT was provided in a breakfast and 371 
preload study (St-Onge et al. 2014). The optimal dose required to beneficially affect appetite 372 
remains elusive. One point that must be taken into consideration is the energy contributed from 373 
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the MCT compared to the decrease in subsequent energy intake it begets. MCT was 374 
administered in a variety of ways in the studies in this review, including duodenal infusions 375 
(Barbera et al. 2000; Feltrin et al. 2004, 2008), being added to beverages (Coleman, Quinn, and 376 
Clegg 2016; Kinsella, Maher, and Clegg 2017; Rolls et al. 1988; St-Onge et al. 2014), a low 377 
calorie formula (Krotkiewski 2001), being added to solid meals (Van Wymelbeke et al. 1998; 378 
Van Wymelbeke, Louis-Sylvestre, and Fantino 2001; Valente et al. 2018), being cooked into 379 
other foods (Clegg et al. 2012; Poppitt et al. 2010; St-Onge et al. 2014), ice cream (Rizzo et al. 380 
2016), and being added into the whole diet (Stubbs and Harbron 1996). One practical limitation 381 
that must be considered is the fact that the majority of these studies added the test oils to other 382 




There are several limitations to this review and meta-analysis. The main limitation to 387 
acknowledge is the fact that one reviewer reviewed all papers, instead of multiple reviewers 388 
screening all titles and a consensus being met. Furthermore, studies were initially excluded 389 
based on titles alone, instead of a title and abstract screening process. These two limitations 390 
mean that incomplete retrieval of records cannot be ruled out.  Only 16 studies were included 391 
based on our criteria, of which 11 were included in the meta-analysis of energy intake 392 
(consisting of 20 subgroups). This highlights the limited data examining the role of MCT in 393 
satiety rather than a limitation of this review, however there are methodological differences in 394 
the studies included which do need to be acknowledged. Three studies used coconut oil as the 395 
means of administering MCT (Rizzo et al. 2016; Poppitt et al. 2010; Valente et al. 2018). One 396 
study included in this review examined the effect of MCT to coconut oil as well as a control 397 
LCT oil, and reported that MCT resulted in lower energy intake compared to both LCT and 398 
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coconut oil (Kinsella, Maher, and Clegg 2017). This could be due to the higher concentration 399 
of lauric acid (~50%) (Denke and Grundy 1992) in coconut oil than in MCT oil (1-3%) (Bach 400 
and Babayan 1982; Clegg 2017). It has been shown that only 20-30% of lauric acid acts as an 401 
MCT, whereas the remainder is packed in chylomicrons as with LCT (Denke and Grundy 402 
1992). This implies that coconut oil may not be a suitable method of examining MCT, and this 403 
may have affected the results of the meta-analysis. A sensitivity analysis was conducted by 404 
removing the one study investigating coconut oil (Rizzo et al. 2016) and the one subgroup that 405 
compared coconut oil and LCT (Kinsella, Maher and Clegg 2017), which led to the effect size 406 
to increase; which supports the notion that coconut oil is not as effective as MCT at inducing 407 
satiety. Two studies, including the only study that reported increased intake after MCT, 408 
administered the oils via infusion and not incorporated into a meal (Feltrin et al. 2008, 2004). 409 
We did not specify in our criteria that studies included required to have the MCT in a meal, 410 
and thus we decided to include these studies, however, the validity of these studies among other 411 
feeding studies could be questioned. Furthermore, the one study that reported an increase intake 412 
after LCT (Feltrin et al. 2004) compared lauric acid (C12) to decanoic (C10) acid, which is 413 
arguably not MCT compared to LCT due to the absorption of lauric acid, as aforementioned. 414 
Removal of these studies did not affect the results of the meta-analysis, and thus they have been 415 
kept in in order to better represent the available data. However, similar to studies investigating 416 
coconut oil, a sensitivity analysis was conducted by removing the two studies which infused 417 
MCT (Feltrin et al. 2004, 2008), and this increased the effect size; meaning the inclusion of 418 
infusion studies weakened the effect of MCT on energy intake. From a practical standpoint, 419 
this further highlights that consumption of MCT leads to suppressed energy intake compared 420 
to LCT. 421 
18 
 
These limitations should be taken into consideration for future research examining this topic, 422 
and also shows the small number of appropriate studies examining the effect of MCT on 423 
appetite and energy intake. 424 
 425 
Conclusion 426 
The present meta-analysis indicates a moderate reduction in energy intake after consumption 427 
of MCT, predominantly at single ad libitum meals, but also total daily energy intake after 428 
daily incorporation of MCT into the diet. Whether this reduction persists past the first meal 429 
after consumption of MCT remains to be elucidated. The systematic review indicates that 430 
there is no effect of MCT on subjective sensations of appetite. Further work is required to 431 
confirm the role of appetite hormones in the satiety response to MCT, but there is currently 432 
no evidence to suggest a hormonal role of MCT satiety.  Due to the small total number of 433 
studies, coupled with the fact not all included a feeding component and only four examined 434 
hormonal responses to MCT, this paper calls for more studies examining MCT and satiety 435 
incorporating these measures, as well as appropriate sources of MCT.  436 
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